A UAE-led research initiative focused on insulin-dependent diabetes mellitus has successfully launched into space as part of the Axiom Mission 4. The mission took off from NASA’s Kennedy Space Center in Florida.

The Suite Ride initiative includes a four-member international crew who will spend 14 days aboard the International Space Station. During this time, they will conduct various experiments and technology demonstrations in a microgravity environment.

One of the key objectives of the mission is to test continuous glucose monitors. The crew will assess the performance and reliability of these monitors while in microgravity. This study is a collaborative effort between Burjeel Holdings, based in Abu Dhabi, and Axiom Space.